Skip to main content
Clinical Trials/CTRI/2025/03/081693
CTRI/2025/03/081693Not yet recruitingPhase 2

Role Of Individualized Homoeopathic Medicines In The Treatment Of Subclinical Hypothyroidism Using Synthesis Repertory An Open Label Prospective Clinical Study

National Institute Of Homoeopathy1 site in 1 country40 target enrollmentStarted: March 18, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
40
Locations
1
Primary Endpoint
To assess Serum TSH Level & Thyroid Symptom Rating Questionnaire (Thy-SRQ)

Study Overview

Brief Summary

Subclinical Hypothyroidism is a clinical condition in which serum TSH is raised, and serum T3 and T4 concentrations are at the lower end of the reference range.

  1. Samples will be selected following preliminary and detailed screening using specified selection criteria.

  2. Inclusion and exclusion criteria are strictly followed.

  3. After consideration of dropout cases, a minimum 40 patients will be enrolled for the study.

  4. Case-taking will be done as per the strict homoeopathic principle.

  5. Baseline scoring will be taken using Thy-SRQ & and Serum TSH levels will be assessed.

  6. Analysis and evaluation of each case will be done.

  7. Miasmatic analysis will be done.

  8. Repertorization will be done in Synthesis Repertory.

  9. Final selection of the remedy will be done after consultation with Materia Medica.

  10. Potency, dose and repetition of the indicated remedies will be guided strictly as per homoeopathic principles.

  11. General (non-medicinal) management including appropriate diet and regimen will be advised.

  12. Subsequent prescriptions (follow-ups) will be generated according to relevant homoeopathic principles and will be recorded in follow-up sheets.

  13. The baseline data will be compared with the data obtained after 6 months.

  14. The score obtained by the patients will be compared and result will be analyzed as per appropriate statistical methods and interference will be done thereafter.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients of both sexes from any religion or socio-demographic background and aged between 18-65 years with high Serum TSH level but less than 20 mIU/ml (5-20 mIU/ml), and T3, T4 within normal range.
  • Patients agreeing to undergo T3, T4, TSH investigation, if required.
  • Patients willing to give written consent to participate in the study.

Exclusion Criteria

  • Patients with serum TSH level more than 20 mIU/ml.
  • Pregnant or lactating women.
  • Patients taking any other treatment for subclinical hypothyroidism from other system of medicine.
  • Patients having the habits of substance abuse and/or dependence.
  • Patients having any uncontrolled systemic illness or any life-threatening disease.
  • Patients not willing to participate in the study, not willing to undergo any investigation, if so advised.

Outcomes

Primary Outcomes

To assess Serum TSH Level & Thyroid Symptom Rating Questionnaire (Thy-SRQ)

Time Frame: Baseline & 6 months

Secondary Outcomes

  • Socio-demographic data(After 6 months)

Investigators

Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Vaka Ashok Kumar

National Institute Of Homoeopathy

Study Sites (1)

Loading locations...

Similar Trials